SPG21

gene product
ABHD21, ACP33, BM-019, GL010, MAST
The protein encoded by this gene binds to the hydrophobic C-terminal amino acids of CD4 which are involved in repression of T cell activation. The interaction with CD4 is mediated by the noncatalytic alpha/beta hydrolase fold domain of this protein. It is thus proposed that this gene product modulates the stimulatory activity of CD4. Mutations in this gene are associated with autosomal recessive spastic paraplegia 21 (SPG21), also known as mast syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
105 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Invitrogen Antibodies
3 antibodies
Novus Biologicals
4 antibodies
antibodies-online
47 antibodies
LifeSpan BioSciences, Inc.
15 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
5 antibodies
Abnova Corporation
3 antibodies
Aviva Systems Biology
2 antibodies
OriGene
2 antibodies
Bethyl Laboratories
1 antibody
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
1 antibody
Creative Diagnostics
5 antibodies
Creative Biolabs
4 antibodies
Abbexa
3 antibodies
Sigma-Aldrich
2 antibodies
Abgent
1 antibody
Leading Biology
1 antibody
Acris Antibodies GmbH
2 antibodies
United States Biological
1 antibody